Cold Agglutinin Disease Market, Global Outlook and Forecast 2022-2028

July 2022 | 63 pages | ID: CDD408F2374DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cold Agglutinin Disease in Global, including the following market information:

Global Cold Agglutinin Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cold Agglutinin Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cold Agglutinin Disease include Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Zydus Cadila, AstraZeneca, Johnson & Johnson, Bayer AG and Sun Pharmaceutical Industries Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cold Agglutinin Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cold Agglutinin Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cold Agglutinin Disease Market Segment Percentages, by Type, 2021 (%)

• Corticosteroids
• Alkylating Agents
• Purine Nucleoside Analogs
• Biologics
• Others

Global Cold Agglutinin Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cold Agglutinin Disease Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Homecare
• Others

Global Cold Agglutinin Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cold Agglutinin Disease Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cold Agglutinin Disease revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cold Agglutinin Disease revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Pfizer Inc.
• GlaxoSmithKline plc
• Novartis AG
• Zydus Cadila
• AstraZeneca
• Johnson & Johnson
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Apellis Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cold Agglutinin Disease Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cold Agglutinin Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COLD AGGLUTININ DISEASE OVERALL MARKET SIZE

2.1 Global Cold Agglutinin Disease Market Size: 2021 VS 2028
2.2 Global Cold Agglutinin Disease Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cold Agglutinin Disease Players in Global Market
3.2 Top Global Cold Agglutinin Disease Companies Ranked by Revenue
3.3 Global Cold Agglutinin Disease Revenue by Companies
3.4 Top 3 and Top 5 Cold Agglutinin Disease Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cold Agglutinin Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cold Agglutinin Disease Players in Global Market
  3.6.1 List of Global Tier 1 Cold Agglutinin Disease Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cold Agglutinin Disease Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cold Agglutinin Disease Market Size Markets, 2021 & 2028
  4.1.2 Corticosteroids
  4.1.3 Alkylating Agents
  4.1.4 Purine Nucleoside Analogs
  4.1.5 Biologics
  4.1.6 Others
4.2 By Type - Global Cold Agglutinin Disease Revenue & Forecasts
  4.2.1 By Type - Global Cold Agglutinin Disease Revenue, 2017-2022
  4.2.2 By Type - Global Cold Agglutinin Disease Revenue, 2023-2028
  4.2.3 By Type - Global Cold Agglutinin Disease Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cold Agglutinin Disease Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Homecare
  5.1.5 Others
5.2 By Application - Global Cold Agglutinin Disease Revenue & Forecasts
  5.2.1 By Application - Global Cold Agglutinin Disease Revenue, 2017-2022
  5.2.2 By Application - Global Cold Agglutinin Disease Revenue, 2023-2028
  5.2.3 By Application - Global Cold Agglutinin Disease Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cold Agglutinin Disease Market Size, 2021 & 2028
6.2 By Region - Global Cold Agglutinin Disease Revenue & Forecasts
  6.2.1 By Region - Global Cold Agglutinin Disease Revenue, 2017-2022
  6.2.2 By Region - Global Cold Agglutinin Disease Revenue, 2023-2028
  6.2.3 By Region - Global Cold Agglutinin Disease Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cold Agglutinin Disease Revenue, 2017-2028
  6.3.2 US Cold Agglutinin Disease Market Size, 2017-2028
  6.3.3 Canada Cold Agglutinin Disease Market Size, 2017-2028
  6.3.4 Mexico Cold Agglutinin Disease Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cold Agglutinin Disease Revenue, 2017-2028
  6.4.2 Germany Cold Agglutinin Disease Market Size, 2017-2028
  6.4.3 France Cold Agglutinin Disease Market Size, 2017-2028
  6.4.4 U.K. Cold Agglutinin Disease Market Size, 2017-2028
  6.4.5 Italy Cold Agglutinin Disease Market Size, 2017-2028
  6.4.6 Russia Cold Agglutinin Disease Market Size, 2017-2028
  6.4.7 Nordic Countries Cold Agglutinin Disease Market Size, 2017-2028
  6.4.8 Benelux Cold Agglutinin Disease Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cold Agglutinin Disease Revenue, 2017-2028
  6.5.2 China Cold Agglutinin Disease Market Size, 2017-2028
  6.5.3 Japan Cold Agglutinin Disease Market Size, 2017-2028
  6.5.4 South Korea Cold Agglutinin Disease Market Size, 2017-2028
  6.5.5 Southeast Asia Cold Agglutinin Disease Market Size, 2017-2028
  6.5.6 India Cold Agglutinin Disease Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cold Agglutinin Disease Revenue, 2017-2028
  6.6.2 Brazil Cold Agglutinin Disease Market Size, 2017-2028
  6.6.3 Argentina Cold Agglutinin Disease Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cold Agglutinin Disease Revenue, 2017-2028
  6.7.2 Turkey Cold Agglutinin Disease Market Size, 2017-2028
  6.7.3 Israel Cold Agglutinin Disease Market Size, 2017-2028
  6.7.4 Saudi Arabia Cold Agglutinin Disease Market Size, 2017-2028
  6.7.5 UAE Cold Agglutinin Disease Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Cold Agglutinin Disease Major Product Offerings
  7.1.4 Sanofi Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Pfizer Inc.
  7.2.1 Pfizer Inc. Corporate Summary
  7.2.2 Pfizer Inc. Business Overview
  7.2.3 Pfizer Inc. Cold Agglutinin Disease Major Product Offerings
  7.2.4 Pfizer Inc. Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Inc. Key News
7.3 GlaxoSmithKline plc
  7.3.1 GlaxoSmithKline plc Corporate Summary
  7.3.2 GlaxoSmithKline plc Business Overview
  7.3.3 GlaxoSmithKline plc Cold Agglutinin Disease Major Product Offerings
  7.3.4 GlaxoSmithKline plc Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline plc Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG Cold Agglutinin Disease Major Product Offerings
  7.4.4 Novartis AG Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.4.5 Novartis AG Key News
7.5 Zydus Cadila
  7.5.1 Zydus Cadila Corporate Summary
  7.5.2 Zydus Cadila Business Overview
  7.5.3 Zydus Cadila Cold Agglutinin Disease Major Product Offerings
  7.5.4 Zydus Cadila Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.5.5 Zydus Cadila Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Cold Agglutinin Disease Major Product Offerings
  7.6.4 AstraZeneca Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Cold Agglutinin Disease Major Product Offerings
  7.7.4 Johnson & Johnson Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Bayer AG
  7.8.1 Bayer AG Corporate Summary
  7.8.2 Bayer AG Business Overview
  7.8.3 Bayer AG Cold Agglutinin Disease Major Product Offerings
  7.8.4 Bayer AG Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.8.5 Bayer AG Key News
7.9 Sun Pharmaceutical Industries Ltd.
  7.9.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
  7.9.2 Sun Pharmaceutical Industries Ltd. Business Overview
  7.9.3 Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Major Product Offerings
  7.9.4 Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Industries Ltd. Key News
7.10 Apellis Pharmaceuticals
  7.10.1 Apellis Pharmaceuticals Corporate Summary
  7.10.2 Apellis Pharmaceuticals Business Overview
  7.10.3 Apellis Pharmaceuticals Cold Agglutinin Disease Major Product Offerings
  7.10.4 Apellis Pharmaceuticals Cold Agglutinin Disease Revenue in Global Market (2017-2022)
  7.10.5 Apellis Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cold Agglutinin Disease Market Opportunities & Trends in Global Market
Table 2. Cold Agglutinin Disease Market Drivers in Global Market
Table 3. Cold Agglutinin Disease Market Restraints in Global Market
Table 4. Key Players of Cold Agglutinin Disease in Global Market
Table 5. Top Cold Agglutinin Disease Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cold Agglutinin Disease Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cold Agglutinin Disease Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cold Agglutinin Disease Product Type
Table 9. List of Global Tier 1 Cold Agglutinin Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cold Agglutinin Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cold Agglutinin Disease Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cold Agglutinin Disease Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cold Agglutinin Disease Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cold Agglutinin Disease Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cold Agglutinin Disease Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cold Agglutinin Disease Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cold Agglutinin Disease Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cold Agglutinin Disease Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cold Agglutinin Disease Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cold Agglutinin Disease Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cold Agglutinin Disease Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cold Agglutinin Disease Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cold Agglutinin Disease Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cold Agglutinin Disease Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Cold Agglutinin Disease Product Offerings
Table 32. Sanofi Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Inc. Corporate Summary
Table 34. Pfizer Inc. Cold Agglutinin Disease Product Offerings
Table 35. Pfizer Inc. Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline plc Corporate Summary
Table 37. GlaxoSmithKline plc Cold Agglutinin Disease Product Offerings
Table 38. GlaxoSmithKline plc Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 39. Novartis AG Corporate Summary
Table 40. Novartis AG Cold Agglutinin Disease Product Offerings
Table 41. Novartis AG Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 42. Zydus Cadila Corporate Summary
Table 43. Zydus Cadila Cold Agglutinin Disease Product Offerings
Table 44. Zydus Cadila Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Cold Agglutinin Disease Product Offerings
Table 47. AstraZeneca Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Cold Agglutinin Disease Product Offerings
Table 50. Johnson & Johnson Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 51. Bayer AG Corporate Summary
Table 52. Bayer AG Cold Agglutinin Disease Product Offerings
Table 53. Bayer AG Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Industries Ltd. Corporate Summary
Table 55. Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Product Offerings
Table 56. Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)
Table 57. Apellis Pharmaceuticals Corporate Summary
Table 58. Apellis Pharmaceuticals Cold Agglutinin Disease Product Offerings
Table 59. Apellis Pharmaceuticals Cold Agglutinin Disease Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cold Agglutinin Disease Segment by Type in 2021
Figure 2. Cold Agglutinin Disease Segment by Application in 2021
Figure 3. Global Cold Agglutinin Disease Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cold Agglutinin Disease Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cold Agglutinin Disease Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cold Agglutinin Disease Revenue in 2021
Figure 8. By Type - Global Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 12. US Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 16. Germany Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 17. France Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 24. China Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 28. India Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 30. Brazil Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cold Agglutinin Disease Revenue Market Share, 2017-2028
Figure 33. Turkey Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cold Agglutinin Disease Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Inc. Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline plc Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis AG Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Zydus Cadila Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer AG Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Apellis Pharmaceuticals Cold Agglutinin Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)